Zhejiang Chimin Pharm Co Ltd (603222) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.84 Million ≈ $562.44K USD) by net assets (CN¥1.49 Billion ≈ $217.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Chimin Pharm Co Ltd (603222) net asset quality to measure how much of total assets are equity-financed.

Zhejiang Chimin Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Chimin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603222 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Chimin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Chimin Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Heilongjiang Transport Development Co Ltd SHG:601188	0.024x
Mennica Polska S.A. WAR:MNC	0.071x
Hanwang Technology Co Ltd SHE:002362	-0.041x
Anhui Zhonghuan Environmental Protection Technology Co Ltd SHE:300692	0.028x
Qualipoly Chemical Corp TW:4722	-0.027x
Dexus Industria REIT AU:DXI	0.022x
NRJ Group PA:NRG	0.062x
Core Lithium Ltd AU:CXO	-0.077x

Annual Cash Flow Conversion Efficiency for Zhejiang Chimin Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 603222 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.31 Billion ≈ $191.04 Million	CN¥-10.35 Million ≈ $-1.51 Million	-0.008x	-117.04%
2024-12-31	CN¥1.57 Billion ≈ $229.47 Million	CN¥72.99 Million ≈ $10.68 Million	0.047x	-44.90%
2023-12-31	CN¥1.66 Billion ≈ $242.89 Million	CN¥140.20 Million ≈ $20.52 Million	0.084x	-26.76%
2022-12-31	CN¥1.77 Billion ≈ $259.65 Million	CN¥204.65 Million ≈ $29.95 Million	0.115x	-45.24%
2021-12-31	CN¥1.37 Billion ≈ $201.14 Million	CN¥289.49 Million ≈ $42.36 Million	0.211x	+32.51%
2020-12-31	CN¥1.05 Billion ≈ $153.10 Million	CN¥166.29 Million ≈ $24.33 Million	0.159x	+11.61%
2019-12-31	CN¥1.07 Billion ≈ $156.99 Million	CN¥152.77 Million ≈ $22.36 Million	0.142x	+20.21%
2018-12-31	CN¥1.05 Billion ≈ $153.15 Million	CN¥123.99 Million ≈ $18.14 Million	0.118x	+65.39%
2017-12-31	CN¥928.28 Million ≈ $135.84 Million	CN¥66.49 Million ≈ $9.73 Million	0.072x	-19.65%
2016-12-31	CN¥808.94 Million ≈ $118.37 Million	CN¥72.12 Million ≈ $10.55 Million	0.089x	-23.45%
2015-12-31	CN¥750.99 Million ≈ $109.89 Million	CN¥87.46 Million ≈ $12.80 Million	0.116x	-33.52%
2014-12-31	CN¥441.55 Million ≈ $64.61 Million	CN¥77.36 Million ≈ $11.32 Million	0.175x	-20.95%
2013-12-31	CN¥488.13 Million ≈ $71.43 Million	CN¥108.19 Million ≈ $15.83 Million	0.222x	-43.57%
2012-12-31	CN¥432.53 Million ≈ $63.29 Million	CN¥169.88 Million ≈ $24.86 Million	0.393x	+357.29%
2011-12-31	CN¥383.04 Million ≈ $56.05 Million	CN¥32.90 Million ≈ $4.81 Million	0.086x	--

About Zhejiang Chimin Pharm Co Ltd

SHG:603222 China Medical Instruments & Supplies

Market Cap

$550.15 Million

CN¥3.76 Billion CNY

Market Cap Rank

#11549 Global

#3211 in China

Share Price

CN¥7.16

Change (1 day)

+2.29%

52-Week Range

CN¥6.79 - CN¥14.06

All Time High

CN¥57.73